Instrument Inactif

Communiqués BETR THER

Actions

BTTX

US62402D1054

Communiqués

11/08/22	MOUN CRES : Better Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update - Form 8-K	PU
28/07/22	MOUN CRES : Better Therapeutics Completes Pivotal Trial of BT-001 for Type 2 Diabetes and Announces Positive Secondary Endpoint Results Following the Earlier Announcement of Positive Primary Endpoint Results - Form 8-K	PU
07/06/22	MOUN CRES : Better Therapeutics Appoints Frank Karbe as Chief Executive Officer - Form 8-K	PU
28/03/22	MOUN CRES : Better Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results - Form 8-K	PU
22/03/22	MOUN CRES : KOL Call Discussing Better Tx's Top Line Results for BT-001 283.3 KB	PU
15/03/22	MOUN CRES : MARCH 15, 2022 Primary Endpoint Day 90 Analysis Better+ THERAPEUTICS - Form 8-K/A	PU
15/03/22	MOUN CRES : Better Therapeutics Announces Positive Primary Endpoint Data from Pivotal Clinical Trial of BT-001, a Prescription Digital Therapeutic (PDT) for Patients with Uncontrolled Type 2 Diabetes - Form 8-K	PU
14/01/22	MOUN CRES : Amendment to Current Report (Form 8-K/A)	PU
16/12/21	Employee Spotlight: Michelle Gearhart	PU
26/11/21	MOUN CRES : UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS - Form 8-K/A	PU
18/11/21	MOUN CRES : Better Therapeutics Completes Enrollment of Pivotal Trial for BT-001, a Prescription Digital Therapeutic for Type 2 Diabetes - Form 8-K	PU
17/11/21	MOUN CRES : Better Therapeutics Appoints Major General Elder Granger, M.D., U.S. Army (retired) to its Board of Directors - Form 8-K	PU
03/11/21	UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS - Form 8-K	PU
03/11/21	BETTER THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sale of Equity Securities, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Amendment or Waiver to Code of Ethics, Change in Shell Company Status, Financial Statements and Exhibits (form 8-K)	AQ
02/11/21	Mass General Brigham Joins Better Therapeutics in Real World Evidence Study Collaboration	BU
29/10/21	Better Therapeutics Closes Business Combination and Debuts on Nasdaq	BU
27/10/21	Mountain Crest Acquisition Corp. II Stockholders Approve Business Combination with Better Therapeutics Inc - Form 8-K	PU
27/10/21	MOUNTAIN CREST ACQUISITION CORP II : Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
27/10/21	Mountain Crest Acquisition Corp. II Stockholders Approve Business Combination with Better Therapeutics Inc.	GL
27/10/21	Mountain Crest Acquisition Corp. II Stockholders Approve Business Combination with Better Therapeutics Inc.	GL
14/10/21	My Journey to Better Therapeutics	PU
13/10/21	Mountain Crest Acquisition Corp. II and Better Therapeutics, Inc. Announce Registration Statement Effectiveness and Scheduled Special Meeting to Approve Business Combination on October 27, 2021	GL
13/10/21	Mountain Crest Acquisition II : Corp. II and Better Therapeutics, Inc. Announce Registration Statement Effectiveness and Scheduled Special Meeting to Approve Business Combination on October 27, 2021	GL
28/09/21	Mountain Crest Acquisition II : SECOND AMENDMENT TO AGREEMENT AND PLAN OF MERGER (Form 8-K)	PU
28/09/21	MOUNTAIN CREST ACQUISITION CORP II : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	AQ